Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PKI PerkinElmer > Detailed Quotes

PKI PerkinElmer

122.310
-0.920-0.75%
Close 09/23 16:00 ET
122.3100.0000.00%
Post Mkt Price 09/23 16:47 ET
High
123.680
Open
122.290
Turnover
103.55M
Low
120.120
Pre Close
123.230
Volume
851.53K
Market Cap
15.44B
P/E(TTM)
22.95
52wk High
202.888
Shares
126.22M
P/E(Static)
15.14
52wk Low
120.120
Float Cap
14.48B
Bid/Ask %
0.00%
Historical High
202.888
Shs Float
118.41M
Volume Ratio
0.88
Historical Low
3.501
Dividend TTM
0.28
Div Yield TTM
2700
P/B
2.15
Dividend LFY
0.23%
Div Yield LFY
2207.51%
Turnover Ratio
0.72%
Amplitude
2.89%
Avg Price
121.608
Lot Size
1
Float Cap
14.48B
Bid/Ask %
0.00%
Historical High
202.888
Shs Float
118.41M
Volume Ratio
0.88
Historical Low
3.501
Dividend TTM
0.28
P/B
2.15
Dividend LFY
0.23%
Turnover Ratio
0.72%
Amplitude
2.89%
Avg Price
121.608
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

    Goldman Sachs builds thematic ETF lineup with three new disruptive funds

    $Goldman Sachs(GS.US)$ built out its thematic ETF lineup with the launch Thursday of three new funds -- the $Goldman Sachs Etf Trust Goldman Sachs New Age Consumer Etf(GBUY.US)$, $GOLDMAN SACHS FUTURE HEALTH CARE EQUITY ETF(GDOC.US)$ and the $GOLDMAN SACHS FUTURE REAL ESTATE AND INFRASTRUCTURE EQUITY ETF(GREI.US)$ .
    All three ETFs trade on the New York Stock Exchange and come with a 0.75% expense ratio. Below is a deeper dive into each:
    Goldman Sachs Future Consumer Equity ETF
    The Goldman Sachs Future Consumer Equity ETF (GBUY) provides exposure for individuals to the future of consumers.
    The fund invests in companies that align with Millennial and Gen Z's interests, as they're some of the most influential and disruptive consumers in the market.
    From a holdings standpoint, the fund comes with 45 positions and has as top holdings $Amazon(AMZN.US)$ weighted at 6.3%, $Alphabet-C(GOOG.US)$ at 5.3% and $Sea(SE.US)$ weighted at 3.2%.
    GBUY ended the day -0.33%.
    Goldman Sachs Future Health Care Equity ETF
    The Goldman Sachs Future Health Care Equity ETF (GDOC) gives market participants the ability to invest in the rapidly changing healthcare sector.
    The ETF provides access to businesses involved in the disruption and innovation aspects of technology firms within healthcare.
    Holdings-wise, GDOC has 63 unique positions that are led by Eli Lilly (NYSE:LLY)$Eli Lilly and Co(LLY.US)$ weighted at 5%, Intuitive $Intuitive Surgical(ISRG.US)$ at 3.8% and $PerkinElmer(PKI.US)$ weighted at 3.8%.
    GDOC ended its first trading day +0.04%.
    Goldman Sachs Future Real Estate and Infrastructure Equity ETF
    The Goldman Sachs Future Real Estate and Infrastructure Equity ETF (GREI) provides exposure to the unique attributes of real estate and infrastructure.
    The fund focuses on firms that offer strong growth potential, low correlations to traditional asset classes and inflation-hedging benefits while being on the right side of disruption.
    GREI comes to market with 46 holdings and has top positions in Vinci $Seabridge Gold(SA.US)$ weighted at 4.8%, $American Tower Corp(AMT.US)$ at 4.8%, and $National Grid(NGG.US)$ at 4.6%.
    GREI finished Thursday +0.13%.
    Popular Time for New Thematic ETFs
    Goldman Sachs isn't the only firm growing its thematic ETF lineup. For instance, VanEck recently launched the VanEck Vectors Smart Home Active UCITS ETF.
    Goldman Sachs builds thematic ETF lineup with three new disruptive funds
    Comment
    Share
    $PerkinElmer(PKI.US)$PKI Will beat earning and revenue estimates. They will be exceptional.
    Comment
    Share
    $PerkinElmer(PKI.US)$ PKI
    PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery
    BusinessWire - Tue Jan 26, 3:47PM CST
    PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings extend the company's leading GPCR analysis portfolio, which includes innovative assays, plate readers, automation technologies and software solutions combined with siRNA, shRNA, CRISPR, and cDNA/ORF libraries to help scientists more easily and accurately characterize receptors, screen compounds and streamline workflows.
    The new assays, which enable researchers to use the preferred cell models of their choice, include the HTRF GTP Gi binding kit, the industry's first TR-FRET based assay for GTP binding; the B-arr2 recruitment kit; and HTRF total kits for B-Arrestin 1, B-Arrestin 2 and AP2. These assays will help scientists continue to better understand the important role GPCRs play in disease by studying the interaction, expression and potential modulation of intracellular proteins involved in GPCR signaling mechanisms.
    ...
    Comment
    Share

No comment yet

Company Overview More
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.
CEO: Dr. Prahlad R. Singh
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...